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Abstract: 
During the production of monoclonal antibodies using a CHO cell culture process, important parameters 
are generally controlled by a feedback mechanism (PID) in order to ensure consistency in both productivity 
and product quality. These parameters typically include pH, dissolved oxygen, and temperature. While 
most of these parameters are controlled very well within their specific dead band range, dissolved oxygen 
at times can be a little more difficult to control. Oscillations in dissolved oxygen concentration are not 
uncommon and these fluctuations can sometime be exacerbated when using an aeration strategy with a 
high mass transfer rate.  
Recently, we observed a cell line that becomes lactogenic accompanied by a drop in product titer due to 
extreme fluctuations in dissolved oxygen concentration.  It was also observed that the antibody lots with 
higher lactate production correlated with increase trisulfide formation between heavy-light chains. 
Consequently, the elevated trisulfide levels correlate to changes in the drug-to-antibody ratio (DAR), when 
used in sulfhydryl-targeted maleimide conjugation.    
Experiments were conducted to determine if lactogenicity is triggered by low concentrations of dissolved 
oxygen or by fluctuations in dissolved oxygen concentration during the cell cultivation process.   Further 
experiments were performed to evaluate if the elevated trisulfide is associated with the lactogenic status 
of the cells or any particular nutrient/metabolite.  Results from these experiments will be presented and 
strategies for better control of the cell culture process and the product quality of antibody-drug 
conjugates will be discussed. 
 
